Steris (NYSE: STE) revenue
Steris reported revenue of $5,936m for fiscal 2026, 8.7% more than in fiscal 2025 ($5,460m). Since fiscal 2018 its revenue has grown by 126.6%, an average growth of 10.8% a year.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2026 | $5,936m | +8.7% | $1,102m | 18.6% |
| 2025 | $5,460m | +6.2% | $866.6m | 15.9% |
| 2024 | $5,139m | +13.3% | $836.1m | 16.3% |
| 2023 | $4,536m | +7.4% | $791.1m | 17.4% |
| 2022 | $4,223m | +35.9% | $477.8m | 11.3% |
| 2021 | $3,108m | +2.5% | $548.4m | 17.6% |
| 2020 | $3,031m | +8.9% | $537.0m | 17.7% |
| 2019 | $2,782m | +6.2% | $411.0m | 14.8% |
| 2018 | $2,620m | — | $399.9m | 15.3% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Questions about the revenue of Steris
- How much revenue did Steris make in fiscal 2026?
- Steris reported revenue of $5,936m for fiscal 2026, compared with $5,460m in fiscal 2025.
- How much has the revenue of Steris grown?
- Between fiscal 2018 and fiscal 2026 it went from $2,620m to $5,936m: 126.6% more, an average growth of 10.8% a year.
- What was the best year for revenue at Steris?
- Of its last 9 fiscal years, fiscal 2026, with $5,936m.
- Where do the figures for Steris come from?
- From the annual report (Form 10-K) that Steris files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Steris files with the SEC. The filing for each fiscal year: 2026 · 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018. More on Steris: the Steris page · annual accounts · net income · dividends paid · insider transactions.
Dividend per share of Steris by fiscal year, with the filing behind every figure: Steris dividend history.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.